Sodium butyrate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Sodium butyrate
Sodium butyrate formula V.1.svg
Names
IUPAC name
Sodium butanoate
Other names
Sodium butyrate
Identifiers
156-54-7 YesY
ChEBI CHEBI:64103 N
ChEMBL ChEMBL62381 N
ChemSpider 8727 N
Jmol-3D images Image
PubChem 5222465
Properties
C4H7NaO2
Molar mass 110.09 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
 N verify (what isYesY/N?)
Infobox references

Sodium butyrate is a compound with formula Na(C3H7COO). It is the sodium salt of butyric acid. It has various effects on cultured mammalian cells including inhibition of proliferation, induction of differentiation and induction or repression of gene expression.[1] As such, it can be used in lab to bring about any of these effects. Specifically, butyrate treatment of cells results in histone hyperacetylation, and butyrate itself inhibits histone deacetylase (HDAC) activity.[2] Butyrate has been an essential vehicle for determining the role of histone acetylation in chromatin structure and function. Inhibition of HDAC activity is estimated to affect the expression of only 2% of mammalian genes.[3]

References[edit]

  1. ^ Kruh, Jacques (1981). "Effects of sodium butyrate, a new pharmacological agent, on cells in culture". Molecular and Cellular Biochemistry 42 (2): 65–82. doi:10.1007/BF00222695. PMID 6174854. 
  2. ^ Candido, E; Reeves, Raymond; Davie, James R. (1978). "Sodium butyrate inhibits histone deacetylation in cultured cells". Cell 14 (1): 105–13. doi:10.1016/0092-8674(78)90305-7. PMID 667927. 
  3. ^ Davie, James R. (2003). "Inhibition of Histone Deacetylase Activity by Butyrate". The Journal of Nutrition 133 (7 Suppl): 2485S–2493S. PMID 12840228. 

Further reading[edit]

  • Govindarajan, Nambirajan; Agis-Balboa, Roberto Carlos; Walter, Jonas; Sananbenesi, Farahnaz; Fischer, André (2011). "Sodium Butyrate Improves Memory Function in an Alzheimer's Disease Mouse Model When Administered at an Advanced Stage of Disease Progression". Journal of Alzheimer's Disease 26 (1): 187–97. doi:10.3233/JAD-2011-110080. PMID 21593570.